Detalles de la búsqueda
1.
Mycophenolate mofetil is associated with inferior overall survival in cytomegalovirus seropositive patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.
Haematologica;
2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38426274
2.
Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age.
Am J Hematol;
99(1): 38-47, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850688
3.
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer;
127(10): 1598-1605, 2021 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33471943
4.
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Acta Haematol;
144(1): 74-81, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32604096
5.
Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant;
26(5): 1013-1020, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32045652
6.
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant;
26(6): 1077-1083, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31786242
7.
Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors.
Cancer;
126(10): 2193-2205, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32125707
8.
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.
Blood;
131(11): 1248-1257, 2018 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29386198
9.
Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens.
Biol Blood Marrow Transplant;
25(5): 1039-1044, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30639822
10.
Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma.
Biol Blood Marrow Transplant;
25(7): 1340-1346, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30763728
11.
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation.
Am J Hematol;
94(12): 1382-1387, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31595538
12.
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant;
24(11): 2197-2203, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30016656
13.
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.
Biol Blood Marrow Transplant;
24(7): 1514-1520, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29448058
14.
Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Biol Blood Marrow Transplant;
24(6): 1232-1236, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28918304
15.
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
Br J Haematol;
201(4): e37-e41, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36916461
16.
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission.
Am J Hematol;
98(2): E35-E37, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36502492
17.
Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma.
Biol Blood Marrow Transplant;
23(7): 1059-1063, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28389254
18.
Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes.
Biol Blood Marrow Transplant;
23(12): 2166-2171, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28844946
19.
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.
Biol Blood Marrow Transplant;
23(8): 1359-1366, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28506845
20.
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
Biol Blood Marrow Transplant;
23(4): 581-587, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28063964